Nath Bio-Genes (India) Limited (NATHBIOGEN) — Financial Results | 4 May 2026

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings

Nath Bio-Genes reported FY26 revenue of ₹4,316 crores, up 19% YoY, driven by cotton (+28% value growth) and maize (+78% growth), though vegetable seeds declined 15%. Cotton now represents 29% of revenue, while paddy holds 29% and others 42%. Gross margin fell to 56% from 63%, but EBITDA margin held steady at 12% despite a 7% YoY revenue dip in Q4. International expansion reached a milestone with Uzbekistan contributing ₹15 crores to revenue. The company emphasized R&D investment, supply chain strength, and farmer-centric innovation to sustain growth.

📄 View Original Announcement (PDF)

About Nath Bio-Genes (India) Limited (NATHBIOGEN)

Fast Moving Consumer Goods · FMCG · Listed on NSE

Market Cap: ₹289.43 Cr P/E: 7.8 ROE: 6.0% ROCE: 7.9% Div Yield: 1.31%

View full NATHBIOGEN stock details →

📡 Get AI alerts when NATHBIOGEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track NATHBIOGEN — Free

📊 More NATHBIOGEN filings

See all NATHBIOGEN filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when NATHBIOGEN files new disclosures

Track NATHBIOGEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track NATHBIOGEN — Free

Free account · 2 AI queries/day